2016 Greetings and Reflections


MPCCC Directors from L-R: Prof John Zalcberg, Prof Gail Risbridger and Dr Peter Briggs

MPCCC Directors from L-R: Prof John Zalcberg, Prof Gail Risbridger and Dr Peter Briggs

Dear MPCCC Members

As 2016 draws to a close, the MPCCC leadership team would like to wish you and your families a safe and happy break over the summer holidays. We would also like to take this opportunity to reflect on 2016 and to consider what 2017 might look like for cancer improvement.

MPCCC aims to support cancer researchers and clinicians to “connect, collaborate, communicate and innovate”.

MPCCC’s tumour stream programs and networking activities help to create linkages across disciplines and organisations, to facilitate opportunities for collective research and service quality improvement, to grow and develop the cancer workforce and to improve awareness of the excellent work undertaken by our partners that will have impact for the future treatment of cancer. MPCCC’s 2015-2016 Annual Report presents some outstanding examples and success stories of the work undertaken by our participants.

Following the long-anticipated release of the Victorian Cancer Plan 2016 – 2020, MPCCC has initiated the development of its own strategic plan.

With the help of our expert consultants from Health Management Advisors (HMA) we have undertaken detailed consultations with our cancer leaders, hosted focus groups at each of the partner organisations, invited patients and GP’s to contribute to the plan and will now be releasing a survey to encourage input from as many stakeholders as possible. We encourage everyone to take the opportunity to have your say so that we can ensure MPCCC is hitting the right targets and servicing its stakeholders effectively. The strategic planning activities will continue into 2017 with a workshop in February to consolidate our findings and reach agreement about the priorities for MPCCC over the next 5 years.

The Medical Research Futures Fund (MRFF) is set to shape the future landscape of medical research, and with $71 million to be distributed by the end of June, the first half of 2017 is likely to be a cracker!  MPCCC is well positioned to respond to the MRFF research and innovation priorities through its alignment with Monash Partners Academic Health Science Centre and our strong leadership in acknowledged priorities like the clinical data registries.

In September 2016 MPCCC announced applications were open for its Cancer Research Grant with the support of Monash Partners and funding from the Victorian Cancer Agency. We look forward to announcing the recipient in early 2017 following the evaluation process.

We also supported five worthy recipients to travel and present their latest research to cancer focussed conferences, whilst building their international network and reputations.

Thanks to the NHMRC’s 2016 grant round, 2017 will be a solid start for our cancer researchers, with over $22.3 million to be injected into Monash based cancer research projects, and an additional $2.5 million to fellowships.

MPCCC’s dedicated leaders and members are working to discover new ways to diagnose and treat cancers, trialling new cancer therapies and identifying ways to deliver the best possible clinical services. Our collective aim is to improve the lives of cancer patients and their families across the southern Melbourne region.

We would like to personally thank all of our partner organisations, clinicians and researchers who have contributed to this year’s fantastic achievements and hope you will join with us  again next year to deliver a promising 2017.


Gail Risbridger, Research Director, MCCC

Peter Briggs, Clinical Director, SMICS

John Zalcberg, Cancer Program Leader, DEPM Monash University